Walleye Trading’s iShares Biotechnology ETF IBB Stock Holding History

Walleye Trading’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,184	Closed	-$5.33M	–	4375
2025 Q4	$5.26M	Buy	31,184 +30,114	+2,814%	+$4.89M	0.01%	1267
2025 Q3	$154K	Sell	1,070 -5,012	-82%	-$684K	﹤0.01%	3503
2025 Q2	$769K	Buy	+6,082	New	+$747K	﹤0.01%	2370
2024 Q1	–	Sell	-5,737	Closed	-$783K	–	5021
2023 Q4	$779K	Buy	5,737 +4,705	+456%	+$574K	﹤0.01%	2698
2023 Q3	$126K	Sell	1,032 -11,341	-92%	-$1.44M	﹤0.01%	3856
2023 Q2	$1.57M	Buy	12,373 +9,582	+343%	+$1.24M	﹤0.01%	1835
2023 Q1	$360K	Sell	2,791 -12,996	-82%	-$1.7M	﹤0.01%	3074
2022 Q4	$2.07M	Buy	+15,787	New	+$2.04M	0.01%	1656
2022 Q1	–	Sell	-251	Closed	-$32.7K	–	5558
2021 Q4	$38K	Sell	251 -5,023	-95%	-$778K	﹤0.01%	4741
2021 Q3	$853K	Buy	+5,274	New	+$888K	﹤0.01%	2380
2021 Q2	–	Sell	-1,376	Closed	-$212K	–	5333
2021 Q1	$207K	Buy	+1,376	New	+$219K	﹤0.01%	3577
2020 Q4	–	Sell	-4,221	Closed	-$603K	–	4734
2020 Q3	$572K	Buy	4,221 +246	+6%	+$33.4K	﹤0.01%	2127
2020 Q2	$543K	Sell	3,975 -13,809	-78%	-$1.76M	﹤0.01%	2217
2020 Q1	$1.92M	Buy	+17,784	New	+$2.05M	0.01%	860
2019 Q3	–	Sell	-424	Closed	-$44.4K	–	4186
2019 Q2	$46K	Sell	424 -6,600	-94%	-$702K	﹤0.01%	3568
2019 Q1	$785K	Sell	7,024 -2,100	-23%	-$230K	0.01%	1882
2018 Q4	$880K	Sell	9,124 -4,887	-35%	-$519K	0.01%	1858
2018 Q3	$1.71M	Buy	14,011 +3,977	+40%	+$468K	0.01%	1496
2018 Q2	$1.1M	Buy	10,034 +1,905	+23%	+$204K	0.01%	1996
2018 Q1	$868K	Sell	8,129 -6,119	-43%	-$678K	0.01%	2064
2017 Q4	$1.52M	Buy	14,248 +11,740	+468%	+$1.25M	0.01%	1543
2017 Q3	$279K	Sell	2,508 -2,880	-53%	-$308K	﹤0.01%	2968
2017 Q2	$557K	Buy	+5,388	New	+$531K	﹤0.01%	2274
2017 Q1	–	Sell	-12,249	Closed	-$1.17M	–	4880
2016 Q4	$1.08M	Sell	12,249 -1,935	-14%	-$176K	0.01%	1450
2016 Q3	$1.37M	Buy	14,184 +12,048	+564%	+$1.15M	0.01%	1276
2016 Q2	$183K	Buy	+2,136	New	+$192K	﹤0.01%	3017
2016 Q1	–	Sell	-402	Closed	-$36K	–	5547
2015 Q4	$45K	Sell	402 -7,056	-95%	-$766K	﹤0.01%	3928
2015 Q3	$754K	Buy	7,458 +7,191	+2,693%	+$863K	0.01%	1257
2015 Q2	$33K	Sell	267 -933	-78%	-$112K	﹤0.01%	3738
2015 Q1	$137K	Sell	1,200 -14,433	-92%	-$1.59M	﹤0.01%	2472
2014 Q4	$1.58M	Buy	15,633 +9,369	+150%	+$911K	0.01%	793
2014 Q3	$571K	Sell	6,264 -14,223	-69%	-$1.25M	0.01%	1206
2014 Q2	$1.75M	Buy	+20,487	New	+$1.61M	0.02%	469
2014 Q1	–	Sell	-44,664	Closed	-$3.72M	–	3697
2013 Q4	$3.38M	Buy	44,664 +39,333	+738%	+$2.79M	0.03%	426
2013 Q3	$372K	Sell	5,331 -3,096	-37%	-$203K	﹤0.01%	1375
2013 Q2	$488K	Buy	+8,427	New	+$487K	﹤0.01%	1263

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Walleye Trading's IBB Position: Q1 2026 in Review

Walleye Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 31,184 shares — an estimated $5.33M sold.

Walleye Trading first reported a position in IBB in Q2 2013 and held it in 36 quarters. The position peaked at $5.26M in Q4 2025. 923 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Walleye Trading reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 31,184 iShares Biotechnology ETF shares in Q1 2026, an estimated $5.33M.
Walleye Trading first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 36 quarters.
Walleye Trading's iShares Biotechnology ETF position peaked at $5.26M in Q4 2025.
923 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.